Michael serves as Research Director for the IMS Institute. He writes and speaks regularly on key  health care topics related to the current and future place of biopharmaceuticals in healthcare.  He brings a deep understanding of complex data sources and analytics from IMS and elsewhere, as well as the historic drivers of performance in key market segments.